{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:29:20Z","timestamp":1762507760011,"version":"3.37.3"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["314730-166609"],"award-info":[{"award-number":["314730-166609"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation pour la Recherche sur le Diab\u00e8te"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0217751","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:37:27Z","timestamp":1559842647000},"page":"e0217751","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Giacomo","family":"Gastaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Schneiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Montet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Tappy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-4806","authenticated-orcid":true,"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"year":"2017","key":"ref1"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"10179","key":"ref3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"F Carrat","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/hepr.13186","article-title":"Restoration of natural killer cell activity by interferon-free direct-acting antiviral combination therapy in chronic hepatitis C patients","volume":"48","author":"I Nakamura","year":"2018","journal-title":"Hepatol Res"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/hepr.13053","article-title":"Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan","volume":"48","author":"T Kaishima","year":"2018","journal-title":"Hepatol Res"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/liv.13900","article-title":"Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C","volume":"39","author":"ZM Younossi","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"M-H Lee","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"F Negro","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic Manifestations of Hepatitis C: A Meta-analysis ofPrevalence, Quality of Life, and Economic Burden","volume":"150","author":"Z Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/jvh.12881","article-title":"Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe","volume":"25","author":"P Cacoub","year":"2018","journal-title":"Journal of viral hepatitis"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"SH Mehta","year":"2003","journal-title":"Hepatology"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/aje\/kwg259","article-title":"Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status","volume":"158","author":"CS Wang","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/liv.13194","article-title":"Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study","volume":"37","author":"Y-J Lin","year":"2017","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"M Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"M Romero-Gomez","year":"2008","journal-title":"Journal of hepatology"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Y Arase","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.25867","article-title":"Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C","volume":"56","author":"A Aghemo","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"462 e1","DOI":"10.1016\/j.cmi.2015.12.030","article-title":"Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents","volume":"22","author":"P Pavone","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cmi.2016.09.021","article-title":"HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?","volume":"23","author":"C Fabrizio","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications","volume":"152","author":"P Nahon","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gutjnl-2017-313983","article-title":"The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection","volume":"67","author":"P Mahale","year":"2018","journal-title":"Gut"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2018.11.022","article-title":"Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events","volume":"156","author":"AA Butt","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"YC Hsu","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis","volume":"67","author":"P Cacoub","year":"2018","journal-title":"Gut"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is the genotype 3 of the hepatitis C virus the new villain?","volume":"59","author":"N Goossens","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.23031","article-title":"Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C","volume":"50","author":"E Vanni","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"R Moucari","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.21634","article-title":"The Hepatitis C Virus Core Protein of Genotypes 3a and 1b Down-Regulates Insulin Receptor Substrate 1 via Genotype-Specific Mechanisms","volume":"45","author":"V Pazienza","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"T Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: does it matter?","volume":"56","author":"E Bugianesi","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"KL Milner","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jvh.12143","article-title":"Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots","volume":"21","author":"KL Milner","year":"2014","journal-title":"J Viral Hepat"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"T Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/jbc.271.1.278","article-title":"The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2","volume":"271","author":"LC Platanias","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2015.07.063","article-title":"Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection","volume":"149","author":"EJ Gane","year":"2015","journal-title":"Gastroenterology"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.ijo.0802760","article-title":"Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans","volume":"28","author":"K Minehira","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"e109134","DOI":"10.1371\/journal.pone.0109134","article-title":"Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study","volume":"9","author":"A Zanchi","year":"2014","journal-title":"PloS one"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/dc12-0540","article-title":"Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial","volume":"36","author":"I Aeberli","year":"2013","journal-title":"Diabetes care"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1152\/jappl.1991.70.1.194","article-title":"Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men","volume":"70","author":"M Hargreaves","year":"1991","journal-title":"J Appl Physiol"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ajcn\/54.3.509","article-title":"Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus","volume":"54","author":"DE Kelley","year":"1991","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"BH Goodpaster","year":"2000","journal-title":"J Appl Physiol (1985)"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00125-011-2275-5","article-title":"Subcutaneous thigh fat area is unrelated to risk of type 2 diabetes in a prospective study of Japanese Americans","volume":"54","author":"D Hoyer","year":"2011","journal-title":"Diabetologia"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0026-0495(99)90265-2","article-title":"Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis","volume":"48","author":"P Schneiter","year":"1999","journal-title":"Metabolism: clinical and experimental"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.22404","article-title":"Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes","volume":"48","author":"S Clement","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"T Poynard","year":"2003","journal-title":"Hepatology"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Y Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4161\/rna.8.2.15011","article-title":"Hepatitis C virus and host cell lipids: an intimate connection","volume":"8","author":"G Alvisi","year":"2011","journal-title":"RNA Biol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4093\/dmj.2017.41.4.316","article-title":"Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4","volume":"41","author":"AA Dawood","year":"2017","journal-title":"Diabetes Metab J"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus","volume":"40","author":"J Hum","year":"2017","journal-title":"Diabetes care"},{"issue":"9","key":"ref50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0043-112656","article-title":"Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up","volume":"55","author":"B Schlevogt","year":"2017","journal-title":"Z Gastroenterol"},{"issue":"13","key":"ref51","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.75.13.6209-6211.2001","article-title":"Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy","volume":"75","author":"SJ Polyak","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"H Knobler","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41467-017-02074-2","article-title":"Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance","volume":"8","author":"X Brenachot","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00005-016-0395-9","article-title":"Role of CX3CL1 in Diseases","volume":"64","author":"W Liu","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cyto.2011.03.001","article-title":"High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV\/HCV co-infected patients with HCV genotype 1","volume":"54","author":"M Garcia-Alvarez","year":"2011","journal-title":"Cytokine"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhep.2007.09.008","article-title":"The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection","volume":"48","author":"HE Wasmuth","year":"2008","journal-title":"J Hepatol"},{"issue":"Pt 8","key":"ref57","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1099\/vir.0.062430-0","article-title":"Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator","volume":"95","author":"K Gouthamchandra","year":"2014","journal-title":"J Gen Virol"},{"issue":"7049","key":"ref58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Q Yang","year":"2005","journal-title":"Nature"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"RCR Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"H Misu","year":"2010","journal-title":"Cell Metab"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clinre.2015.12.003","article-title":"Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study","volume":"40","author":"SA Ali","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"N Stefan","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"N Stefan","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nutres.2012.11.007","article-title":"The ratio of insulin-like growth factor-I\/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance","volume":"33","author":"T Himoto","year":"2013","journal-title":"Nutr Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1038\/srep10227","article-title":"Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population","volume":"5","author":"Y Liu","year":"2015","journal-title":"Sci Rep"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2337\/db09-0277","article-title":"Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells","volume":"58","author":"H Sell","year":"2009","journal-title":"Diabetes"},{"issue":"9","key":"ref67","first-page":"661","article-title":"Chemerin, vaspin and insulin resistance in chronic hepatitis C","volume":"17","author":"M Kukla","year":"2009","journal-title":"J Viral Hepat"},{"issue":"17","key":"ref68","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.0408452102","article-title":"Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice","volume":"102","author":"A Xu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.metabol.2008.11.016","article-title":"Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis","volume":"58","author":"T Ebert","year":"2009","journal-title":"Metabolism"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.diabres.2014.07.026","article-title":"Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis","volume":"106","author":"R Feng","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"30","key":"ref71","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"K Hida","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"BS Youn","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2011.08.083","article-title":"Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase\/Akt pathway","volume":"413","author":"CH Jung","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"ref74","doi-asserted-by":"crossref","first-page":"15100","DOI":"10.1074\/jbc.M112.350215","article-title":"Proinflammatory actions of visfatin\/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity","volume":"287","author":"C Jacques","year":"2012","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0217751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T18:47:11Z","timestamp":1663613231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0217751"}},"subtitle":[],"editor":[{"given":"Jee-Fu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0217751","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}